Evidence mapPaperPMID 40725147Full record

ReviewInternational journal of molecular sciences2025

Spatiotemporal Heterogeneity of Tumor Glucose Metabolism Reprogramming: From Single-Cell Mechanisms to Precision Interventions.

Xiaoxue Chai, Qian Tao, Lili Li

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xiaoxue ChaiCancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Center for Cancer, The Chinese University of Hong Kong, Shatin, Hong Kong.
Qian TaoCancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Center for Cancer, The Chinese University of Hong Kong, Shatin, Hong Kong.
Lili LiCancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Center for Cancer, The Chinese University of Hong Kong, Shatin, Hong Kong.

Funding

NSFC/RGC Joint Research Scheme N_CUHK419/24Research Grants Council, University Grants Committee 14102923Research Grants Council, University Grants Committee 14111924
6 · The paper itself

Abstract

Glucose metabolism reprogramming as a defining hallmark of cancer has become a pivotal frontier in oncology research. Recent technological advances in single-cell sequencing, spatial omics, and metabolic imaging have transformed the field from static bulk analyses to dynamic investigations of spatiotemporal heterogeneity at a single-cell resolution. This review systematically summarizes the current knowledge on tumor glucose metabolism dynamics, discussing spatial heterogeneity and temporal evolution patterns, metabolic subpopulation interactions revealed by single-cell metabolomics, the glucose metabolism-epigenetics-immunology regulatory axis, and therapeutic strategies targeting metabolic vulnerabilities. Recent technological advances in single-cell sequencing and spatial omics have transformed our understanding of tumor glucose metabolism by providing high-resolution insights into metabolic heterogeneity and regulatory mechanisms, contrasting with classical bulk analyses. Spatiotemporal heterogeneity critically influences therapeutic outcomes by enabling tumor cells to adapt metabolically under selective pressures (e.g., hypoxia, nutrient deprivation), fostering treatment resistance and relapse. Deciphering these dynamics is essential for developing spatiotemporally targeted strategies that address intratumoral diversity and microenvironmental fluctuations. By integrating cutting-edge advances, this review deepens our understanding of tumor metabolic complexity and provides a conceptual framework for developing spatiotemporally precise interventions.

Indexed as

GlucoseNeoplasmsAnimalsHumansMetabolic ReprogrammingMetabolomicsPrecision MedicineSingle-Cell AnalysisTumor MicroenvironmentGlucoseglucose metabolism reprogrammingspatiotemporal heterogeneitytumor

Identifiers

PMID40725147
PMCPMC12295594

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.